CUVL logo

Clinuvel Pharmaceuticals Ltd.

CUVL
Healthcare|Medical - Pharmaceuticals|AU
$5.10
+0.08 (+1.59%)
Next Earnings Report
Feb 23, 2027
EPS est. $0.18 · Revenue est. $26.0M
Financing Filings (last 12 months)
0
No shelf registrations or offering prospectuses filed.

Upcoming Data Readouts (0)

No upcoming completion dates found in active trials.

Awaiting Results (1)

Trials past primary completion date but still active — data readout may be imminent.

Dec 2025
P3
A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo
NCT06109649

SEC Filings (2)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 30, 202620-FAnnual report (foreign)DocumentIndex
Oct 30, 20266-KForeign issuer reportDocumentIndex